Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512031 · ClinicalTrials.gov registry record
Characterizing PAI-1 Modulation on Monocyte Adhesion
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 50
- Enrollment target
NCT00512031 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 50 participants.
The verdict
NCT00512031 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00512031
The ClinicalTrials.gov registry entry for NCT00512031 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00512031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00512031 about?
NCT00512031 is a clinical study titled "Characterizing PAI-1 Modulation on Monocyte Adhesion". To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.
What is the current status of trial NCT00512031?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2007-01. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00512031?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.